Literature DB >> 35110883

Resection of Asymptomatic Primary Tumor with Synchronous Unresectable Colorectal Metastasis-Is It Reasonable?

Mufaddal Kazi1, Sanket Bankar2, Avanish Saklani1.   

Abstract

As much as 30% of colorectal cancers at presentation may have distant metastasis. Asymptomatic primary tumors in the face of synchronous, unresectable metastasis are usually treated with systemic therapy alone. However, data to support or reject primary tumor resection exists and we are yet to come to a definite conclusion. Multiple randomized trials that attempted to address this question failed to accrue adequate patients. The more recent Japanese trial, however, demonstrated a small detriment in overall survival with primary tumor resection. Early cessation of trial with subsequent underpowered results and lack of representation of rectal tumors are key drawbacks of this study. Finally, a balance has to be struck between the risks of tumor-relatedcomplications on systemic therapy with consequent emergency operative morbidity and that of delays in systemic therapy due to primary tumor resection upfront. © Indian Association of Surgical Oncology 2021.

Entities:  

Keywords:  Colorectal cancer; Metastatic; Primary tumor resection

Year:  2021        PMID: 35110883      PMCID: PMC8763984          DOI: 10.1007/s13193-021-01460-z

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  15 in total

1.  Colorectal Cancer in India: An Audit from a Tertiary Center in a Low Prevalence Area.

Authors:  Prachi S Patil; Avanish Saklani; Pravir Gambhire; Shaesta Mehta; Reena Engineer; Ashwin De'Souza; Supriya Chopra; Munita Bal
Journal:  Indian J Surg Oncol       Date:  2017-04-22

Review 2.  Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer.

Authors:  Roberto Cirocchi; Stefano Trastulli; Iosief Abraha; Nereo Vettoretto; Carlo Boselli; Alessandro Montedori; Amilcare Parisi; Giuseppe Noya; Cameron Platell
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

3.  Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes.

Authors:  Pascal Gervaz; Laura Rubbia-Brandt; Axel Andres; Pietro Majno; Arnaud Roth; Philippe Morel; Gilles Mentha
Journal:  Ann Surg Oncol       Date:  2010-04-20       Impact factor: 5.344

4.  Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials.

Authors:  Matthieu Faron; Jean-Pierre Pignon; David Malka; Abderrahmane Bourredjem; Jean-Yves Douillard; Antoine Adenis; Dominique Elias; Olivier Bouché; Michel Ducreux
Journal:  Eur J Cancer       Date:  2014-11-24       Impact factor: 9.162

5.  Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.

Authors:  Rajendra Badwe; Rohini Hawaldar; Nita Nair; Rucha Kaushik; Vani Parmar; Shabina Siddique; Ashwini Budrukkar; Indraneel Mittra; Sudeep Gupta
Journal:  Lancet Oncol       Date:  2015-09-09       Impact factor: 41.316

6.  Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10.

Authors:  Laurence E McCahill; Greg Yothers; Saima Sharif; Nicholas J Petrelli; Lily Lau Lai; Naftali Bechar; Jeffrey K Giguere; Shaker R Dakhil; Louis Fehrenbacher; Samia H Lopa; Lawrence D Wagman; Michael J O'Connell; Norman Wolmark
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

7.  Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.

Authors:  Arnaud Méjean; Alain Ravaud; Simon Thezenas; Sandra Colas; Jean-Baptiste Beauval; Karim Bensalah; Lionnel Geoffrois; Antoine Thiery-Vuillemin; Luc Cormier; Hervé Lang; Laurent Guy; Gwenaelle Gravis; Frederic Rolland; Claude Linassier; Eric Lechevallier; Christian Beisland; Michael Aitchison; Stephane Oudard; Jean-Jacques Patard; Christine Theodore; Christine Chevreau; Brigitte Laguerre; Jacques Hubert; Marine Gross-Goupil; Jean-Christophe Bernhard; Laurence Albiges; Marc-Olivier Timsit; Thierry Lebret; Bernard Escudier
Journal:  N Engl J Med       Date:  2018-06-03       Impact factor: 91.245

8.  Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial.

Authors:  Axel Bex; Peter Mulders; Michael Jewett; John Wagstaff; Johannes V van Thienen; Christian U Blank; Roland van Velthoven; Maria Del Pilar Laguna; Lori Wood; Harm H E van Melick; Maureen J Aarts; J B Lattouf; Thomas Powles; Igle Jan de Jong Md PhD; Sylvie Rottey; Bertrand Tombal; Sandrine Marreaud; Sandra Collette; Laurence Collette; John Haanen
Journal:  JAMA Oncol       Date:  2019-02-01       Impact factor: 31.777

9.  Patient colon and rectal operative outcomes when treated with immune checkpoint inhibitors.

Authors:  Giacomo Calini; Mohamed A Abd El Aziz; Solafah Abdalla; Hamedelneel A Saeed; Jenna K Lovely; Anne-Lise D D'Angelo; Kevin T Behm; Dorin T Colibaseanu; Kellie L Mathis; David W Larson
Journal:  Eur J Surg Oncol       Date:  2021-04-02       Impact factor: 4.424

10.  Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial.

Authors:  Yukihide Kanemitsu; Kohei Shitara; Junki Mizusawa; Tetsuya Hamaguchi; Dai Shida; Koji Komori; Satoshi Ikeda; Hitoshi Ojima; Hideyuki Ike; Akio Shiomi; Jun Watanabe; Yasumasa Takii; Takashi Yamaguchi; Kenji Katsumata; Masaaki Ito; Junji Okuda; Ryoji Hyakudomi; Yasuhiro Shimada; Hiroshi Katayama; Haruhiko Fukuda
Journal:  J Clin Oncol       Date:  2021-02-09       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.